Nestmedic Statistics

Total Valuation

Nestmedic has a market cap or net worth of PLN 29.10 million. The enterprise value is 32.35 million.

Market Cap	29.10M
Enterprise Value	32.35M

Important Dates

The last earnings date was Monday, November 10, 2025.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Nestmedic has 43.11 million shares outstanding. The number of shares has increased by 27.78% in one year.

Current Share Class	43.11M
Shares Outstanding	43.11M
Shares Change (YoY)	+27.78%
Shares Change (QoQ)	+8.92%
Owned by Insiders (%)	15.43%
Owned by Institutions (%)	3.71%
Float	19.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	27.62
PB Ratio	5.12
P/TBV Ratio	5.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.87
EV / Sales	30.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.91, with a Debt / Equity ratio of 0.63.

Current Ratio	0.91
Quick Ratio	0.40
Debt / Equity	0.63
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17.80

Financial Efficiency

Return on equity (ROE) is -110.20% and return on invested capital (ROIC) is -31.04%.

Return on Equity (ROE)	-110.20%
Return on Assets (ROA)	-22.08%
Return on Invested Capital (ROIC)	-31.04%
Return on Capital Employed (ROCE)	-73.31%
Revenue Per Employee	351,212
Profits Per Employee	-1.57M
Employee Count	4
Asset Turnover	0.09
Inventory Turnover	0.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.32% in the last 52 weeks. The beta is 0.16, so Nestmedic's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	-1.32%
50-Day Moving Average	0.77
200-Day Moving Average	0.61
Relative Strength Index (RSI)	37.84
Average Volume (20 Days)	41,049

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nestmedic had revenue of PLN 1.05 million and -4.71 million in losses. Loss per share was -0.14.

Revenue	1.05M
Gross Profit	736,481
Operating Income	-4.30M
Pretax Income	-4.71M
Net Income	-4.71M
EBITDA	-4.17M
EBIT	-4.30M
Loss Per Share	-0.14

Full Income Statement

Balance Sheet

The company has 324,450 in cash and 3.57 million in debt, giving a net cash position of -3.25 million or -0.08 per share.

Cash & Cash Equivalents	324,450
Total Debt	3.57M
Net Cash	-3.25M
Net Cash Per Share	-0.08
Equity (Book Value)	5.69M
Book Value Per Share	0.13
Working Capital	-606,110

Full Balance Sheet

Cash Flow

Operating Cash Flow	-5.56M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	69.90%
Operating Margin	-408.26%
Pretax Margin	-447.08%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nestmedic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.78%
Shareholder Yield	-27.78%
Earnings Yield	-16.19%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nestmedic has an Altman Z-Score of -2.52 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.52
Piotroski F-Score	2